SCHEMBL14720329

SCHEMBL14720329

COC1CCC(O)(c2ccc(C=C3CCN(C4CCC4)CC3)cn2)CC1

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 14/20 0.35
CCR2 P41597 1/20 0.33
KCNH2 Q12809 1/20 0.33
ACACB O00763 1/20 0.31
ACACA Q13085 1/20 0.31
BACE1 P56817 1/20 0.31
CYP2D6 P10635 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720519 0.84 HRH3 (0.34) HRH3
SCHEMBL14720799 0.83 HRH3 (0.32) HRH3
SCHEMBL14731171 0.82 FLT3 (0.35) KCNH2
SCHEMBL14721393 0.82 HRH3 (0.36) HRH3KMT2A
SCHEMBL14721517 0.81 HRH3 (0.32) HRH3
SCHEMBL14720611 0.81 HRH3 (0.32) HRH3
SCHEMBL14720610 0.81 HRH3 (0.32) HRH3
SCHEMBL14721036 0.80 HRH3 (0.35) HRH3CCR2KCNH2
SCHEMBL14720597 0.79 POLB (0.38) HRH3KCNH2CYP2D6KMT2A
SCHEMBL14721390 0.78 DRD1 (0.33) HRH3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed